"The brown bag" and other approaches to decreasing polypharmacy in the elderly
Thomas, D.R.
North Carolina Medical Journal 52(11): 565-566
1991
ISSN/ISBN: 0029-2559 PMID: 1745292 Document Number: 370462
Document emailed within 1 workday
Related Documents
Rajska-Neumann, A.; Szymański, Mł.; Balcer, N.; Grześkowiak, E.; Szałek, E.; Wieczorowska-Tobis, K. 2005: Is smoking a determinant of polypharmacy among elderly subject? Przeglad Lekarski 62(10): 1145-1147Veehof, L.J.; Stewart, R.; Haaijer-Ruskamp, F.M.; Meyboom-de Jong, B. 1999: Chronic polypharmacy in one-third of the elderly in family practice Nederlands Tijdschrift Voor Geneeskunde 143(2): 93-97
Ransmayr, G.; Künig, G.; Neubauer, M.; Wagner, M.; Bösch, S.; Kreczy-Kleedorfer, B. 1993: Is the decreasing responsiveness of axial motor symptoms to L-dopa in elderly parkinsonian patients related to age-associated nonparkinsonian pathologies? Advances in Neurology 60: 685-689
Korja, M.; Lehto, H.; Juvela, S.; Kaprio, J. 2016: Incidence of subarachnoid hemorrhage is decreasing together with decreasing smoking rates Duodecim; Laaketieteellinen Aikakauskirja 132(18): 1668
Chong, S.-A.; Ravichandran, N.; Poon, L.-Y.; Soo, K.-L.; Verma, S. 2006: Reducing polypharmacy through the introduction of a treatment algorithm: use of a treatment algorithm on the impact on polypharmacy Annals of the Academy of Medicine Singapore 35(7): 457-460
Aronson, S.M. 2004: What hath Brown wrought? A preliminary analysis of Brown University's first ten medical school graduating classes Medicine and Health Rhode Island 87(12): 364-368
Krähmer, N.; Hahn, E.G. 2005: Complementary and alternative medical approaches to infection prophylaxis in the elderly MMW Fortschritte der Medizin 147(41): 30-33
Di Carlo, I.; Toro, A.; Sparatore, F.; Primo, S.; Barbagallo, F.; Di Blasi, M. 2006: Emergency gastric ulcer complications in elderly. Factors affecting the morbidity and mortality in relation to therapeutic approaches Minerva Chirurgica 61(4): 325-332
Iakovlev, S.V.; Glezer, M.G.; Kholodov, L.E.; Chistova, V.S.; Mikhaĭlov, A.A. 1986: Pharmacodynamic and pharmacokinetic approaches to optimization of the use of digoxin in the subacute period of myocardial infarction in late middle-age and elderly patients Kardiologiia 26(9): 92-95
Lareau, L.S. 1983: Needs assessment of the elderly: conclusions and methodological approaches Evaluation des besoins chez les personnes âgées: conclusions et approches méthodologiques The Gerontologist 23(5): 518-526
Leppik, I.E. 2000: Monotherapy and polypharmacy Neurology 55(11 Suppl. 3): S25-S29
Ryan, F. 1987: Polytherapy not polypharmacy Medical Journal of Australia 147(6): 316
Shepherd, M. 1998: The risks of polypharmacy Nursing Times 94(32): 60-62
Dunn, H.P. 1986: Polypharmacy record New Zealand Medical Journal 99(810): 728
Shakib, S. 2002: Problems of polypharmacy Australian Family Physician 31(2): 125-128
Chowdhury, K.L.; Jalali, R.K.; Abrol, A.; Saproo, R.K.; Shah, B.A.; Tramboo, R. 1991: Polypharmacy and tardive dyskinesia Journal of the Association of Physicians of India 39(6): 501-503
Myers, L.W.; Phillips, J.T. 1996: Polypharmacy in multiple sclerosis Epilepsy Research. Suppl 11: 181-195
Madan, B.R. 1971: Polypharmacy--more sinning than sinned against Indian Journal of Physiology and Pharmacology 15(3): 87-91
Freudenreich, O.; Goff, D.C. 2003: Polypharmacy in schizophrenia: a fuzzy concept Journal of Clinical Psychiatry 64(9): 1132; Author Reply 1132-3
Greenleaf Brown, L. 2016: Untangling Polypharmacy in Older Adults Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 25(6): 408-411